Our R&D Approach Rigorous & science-led
Curium is committed to advancing nuclear medicine through responsible, science-led research and development.
We apply a rigorous, science-led approach across key stages of the radiopharmaceutical lifecycle, from early discovery through development and delivery.
Our teams bring together scientific, clinical, manufacturing, and regulatory expertise to help ensure innovation is pursued responsibly, with quality, safety, and patient impact at the centre of our work.
Our R&D approach is guided by three core principles
Scientific rigour
Advancing innovation through robust science, clinical relevance, and evidence-based evaluation.
Integrated execution
Integrating research and clinical development with manufacturing, regulatory quality, and supply expertise to address the unique requirements of radiopharmaceutical development.
Patient-focus
Advancing radiodiagnostic and radiotherapeutic solutions with the aim of addressing unmet need and supporting patient care.
As science and clinical needs evolve, Curium remains focused on responsible innovation, scientific excellence, and operational quality.
Meet our innovators
“We are trusted to deliver on time, every time.”
James Portwood, Chief Operations Officer
“The medicines that we offer these families are going to give them hope... and I get to be part of that.”
Kristy Wake - Computerized Maintenance Management Systems
“Every day brings a new challenge, but every dose we produce has the power to change a patient's life.”
Mehmet Antman - Production Executive
“Seeing a new medicine go from a proof of concept in a flask, to a treatment that reaches patients, is the is the most rewarding part of my job.”
Bruce Walters - R&D Engineer